An update on therapeutic opportunities offered by cancer glycolytic metabolism

Carlotta Granchi, Daniele Fancelli, Filippo Minutolo

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Almost all invasive cancers, regardless of tissue origin, are characterized by specific modifications of their cellular energy metabolism. In fact, a strong predominance of aerobic glycolysis over oxidative phosphorylation (Warburg effect) is usually associated with aggressive tumour phenotypes. This metabolic shift offers a survival advantage to cancer cells, since they may continue to produce energy and anabolites even when they are exposed to either transient or permanent hypoxic conditions. Moreover, it ensures a high production rate of glycolysis intermediates, useful as building blocks for fast cell proliferation of cancer cells. This peculiar metabolic profile may constitute an ideal target for therapeutic interventions that selectively hit cancer cells with minimal residual systemic toxicity. In this review we provide an update about some of the most recent advances in the discovery of new bioactive molecules that are able to interfere with cancer glycolysis.

Original languageEnglish
Pages (from-to)4915-4925
Number of pages11
JournalBioorganic and Medicinal Chemistry Letters
Volume24
Issue number21
DOIs
Publication statusPublished - Nov 1 2014

Fingerprint

Metabolism
Cells
Glycolysis
Neoplasms
Cell proliferation
Toxicity
Tumors
Therapeutics
Tissue
Molecules
Metabolome
Oxidative Phosphorylation
Energy Metabolism
Cell Proliferation
Phenotype

Keywords

  • Antitumor agents
  • Cancer metabolism
  • Glycolysis
  • Hypoxia
  • Warburg effect

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Molecular Biology
  • Molecular Medicine
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science
  • Medicine(all)

Cite this

An update on therapeutic opportunities offered by cancer glycolytic metabolism. / Granchi, Carlotta; Fancelli, Daniele; Minutolo, Filippo.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 24, No. 21, 01.11.2014, p. 4915-4925.

Research output: Contribution to journalArticle

Granchi, Carlotta ; Fancelli, Daniele ; Minutolo, Filippo. / An update on therapeutic opportunities offered by cancer glycolytic metabolism. In: Bioorganic and Medicinal Chemistry Letters. 2014 ; Vol. 24, No. 21. pp. 4915-4925.
@article{053555a8ade249f68e105eeae4ace4ef,
title = "An update on therapeutic opportunities offered by cancer glycolytic metabolism",
abstract = "Almost all invasive cancers, regardless of tissue origin, are characterized by specific modifications of their cellular energy metabolism. In fact, a strong predominance of aerobic glycolysis over oxidative phosphorylation (Warburg effect) is usually associated with aggressive tumour phenotypes. This metabolic shift offers a survival advantage to cancer cells, since they may continue to produce energy and anabolites even when they are exposed to either transient or permanent hypoxic conditions. Moreover, it ensures a high production rate of glycolysis intermediates, useful as building blocks for fast cell proliferation of cancer cells. This peculiar metabolic profile may constitute an ideal target for therapeutic interventions that selectively hit cancer cells with minimal residual systemic toxicity. In this review we provide an update about some of the most recent advances in the discovery of new bioactive molecules that are able to interfere with cancer glycolysis.",
keywords = "Antitumor agents, Cancer metabolism, Glycolysis, Hypoxia, Warburg effect",
author = "Carlotta Granchi and Daniele Fancelli and Filippo Minutolo",
year = "2014",
month = "11",
day = "1",
doi = "10.1016/j.bmcl.2014.09.041",
language = "English",
volume = "24",
pages = "4915--4925",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "21",

}

TY - JOUR

T1 - An update on therapeutic opportunities offered by cancer glycolytic metabolism

AU - Granchi, Carlotta

AU - Fancelli, Daniele

AU - Minutolo, Filippo

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Almost all invasive cancers, regardless of tissue origin, are characterized by specific modifications of their cellular energy metabolism. In fact, a strong predominance of aerobic glycolysis over oxidative phosphorylation (Warburg effect) is usually associated with aggressive tumour phenotypes. This metabolic shift offers a survival advantage to cancer cells, since they may continue to produce energy and anabolites even when they are exposed to either transient or permanent hypoxic conditions. Moreover, it ensures a high production rate of glycolysis intermediates, useful as building blocks for fast cell proliferation of cancer cells. This peculiar metabolic profile may constitute an ideal target for therapeutic interventions that selectively hit cancer cells with minimal residual systemic toxicity. In this review we provide an update about some of the most recent advances in the discovery of new bioactive molecules that are able to interfere with cancer glycolysis.

AB - Almost all invasive cancers, regardless of tissue origin, are characterized by specific modifications of their cellular energy metabolism. In fact, a strong predominance of aerobic glycolysis over oxidative phosphorylation (Warburg effect) is usually associated with aggressive tumour phenotypes. This metabolic shift offers a survival advantage to cancer cells, since they may continue to produce energy and anabolites even when they are exposed to either transient or permanent hypoxic conditions. Moreover, it ensures a high production rate of glycolysis intermediates, useful as building blocks for fast cell proliferation of cancer cells. This peculiar metabolic profile may constitute an ideal target for therapeutic interventions that selectively hit cancer cells with minimal residual systemic toxicity. In this review we provide an update about some of the most recent advances in the discovery of new bioactive molecules that are able to interfere with cancer glycolysis.

KW - Antitumor agents

KW - Cancer metabolism

KW - Glycolysis

KW - Hypoxia

KW - Warburg effect

UR - http://www.scopus.com/inward/record.url?scp=84908006686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908006686&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2014.09.041

DO - 10.1016/j.bmcl.2014.09.041

M3 - Article

VL - 24

SP - 4915

EP - 4925

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 21

ER -